Pre-op chemo timing no advantage in resectable NSCLC
The timing of chemotherapy in relation to surgery does not appear to influence survival in patients with early-stage non-small-cell lung cancer, a randomized trial has found.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine